| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 28.638 | 51.903 | 73.598 | 51.470 | 62.752 | 87.030 | 127.450 | 126.347 | 128.281 |
| Total Income - EUR | - | 28.638 | 51.915 | 73.656 | 51.470 | 62.753 | 87.033 | 127.451 | 126.347 | 129.421 |
| Total Expenses - EUR | - | 22.109 | 27.744 | 39.064 | 29.478 | 29.352 | 29.094 | 47.701 | 59.368 | 66.343 |
| Gross Profit/Loss - EUR | - | 6.529 | 24.171 | 34.592 | 21.991 | 33.401 | 57.939 | 79.750 | 66.979 | 63.078 |
| Net Profit/Loss - EUR | - | 6.041 | 23.652 | 33.856 | 21.509 | 32.951 | 57.086 | 78.694 | 65.741 | 59.273 |
| Employees | - | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 |
Check the financial reports for the company - Electrodiagnostic Neoclinic S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 4.420 | 3.760 | 3.120 | 2.505 | 1.905 | 2.095 | 6.453 | 4.837 |
| Current Assets | - | 6.742 | 23.409 | 34.174 | 27.354 | 34.557 | 60.240 | 87.733 | 67.376 | 61.519 |
| Inventories | - | 4.278 | 1.711 | 5.933 | 2.236 | 1.367 | 0 | 162 | 0 | 0 |
| Receivables | - | 133 | 0 | 1.912 | 645 | 586 | 42.004 | 60.305 | 54.430 | 42.395 |
| Cash | - | 2.331 | 21.698 | 26.329 | 24.473 | 32.604 | 18.236 | 27.267 | 12.947 | 19.124 |
| Shareholders Funds | - | 1.632 | 26.670 | 36.819 | 24.414 | 35.801 | 59.873 | 81.489 | 68.528 | 62.044 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 5.110 | 1.159 | 1.116 | 6.061 | 1.261 | 2.272 | 8.339 | 5.302 | 4.312 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Electrodiagnostic Neoclinic S.r.l.